Masimo Total Liabilities and Share Holders Equity 2010-2024 | MASI
Masimo total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Masimo total liabilities and share holders equity for the quarter ending December 31, 2024 was $2.626B, a 13.67% decline year-over-year.
- Masimo total liabilities and share holders equity for 2024 was $2.626B, a 13.67% decline from 2023.
- Masimo total liabilities and share holders equity for 2023 was $3.042B, a 5.27% decline from 2022.
- Masimo total liabilities and share holders equity for 2022 was $3.211B, a 70.14% increase from 2021.
| Masimo Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $2,626 |
| 2023 | $3,042 |
| 2022 | $3,211 |
| 2021 | $1,887 |
| 2020 | $1,713 |
| 2019 | $1,396 |
| 2018 | $1,155 |
| 2017 | $905 |
| 2016 | $821 |
| 2015 | $602 |
| 2014 | $565 |
| 2013 | $439 |
| 2012 | $375 |
| 2011 | $366 |
| 2010 | $310 |
| 2009 | $356 |
| Masimo Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2,626 |
| 2024-09-30 | $3,088 |
| 2024-06-30 | $2,894 |
| 2024-03-31 | $2,958 |
| 2023-12-31 | $3,042 |
| 2023-09-30 | $2,996 |
| 2023-06-30 | $3,011 |
| 2023-03-31 | $3,116 |
| 2022-12-31 | $3,211 |
| 2022-09-30 | $3,056 |
| 2022-06-30 | $2,961 |
| 2022-03-31 | $1,909 |
| 2021-12-31 | $1,887 |
| 2021-09-30 | $1,767 |
| 2021-06-30 | $1,682 |
| 2021-03-31 | $1,598 |
| 2020-12-31 | $1,713 |
| 2020-09-30 | $1,713 |
| 2020-06-30 | $1,636 |
| 2020-03-31 | $1,475 |
| 2019-12-31 | $1,396 |
| 2019-09-30 | $1,314 |
| 2019-06-30 | $1,230 |
| 2019-03-31 | $1,179 |
| 2018-12-31 | $1,155 |
| 2018-09-30 | $1,096 |
| 2018-06-30 | $1,007 |
| 2018-03-31 | $950 |
| 2017-12-31 | $905 |
| 2017-09-30 | $906 |
| 2017-06-30 | $896 |
| 2017-03-31 | $878 |
| 2016-12-31 | $821 |
| 2016-09-30 | $639 |
| 2016-06-30 | $603 |
| 2016-03-31 | $621 |
| 2015-12-31 | $602 |
| 2015-09-30 | $578 |
| 2015-06-30 | $584 |
| 2015-03-31 | $575 |
| 2014-12-31 | $565 |
| 2014-09-30 | $532 |
| 2014-06-30 | $499 |
| 2014-03-31 | $459 |
| 2013-12-31 | $439 |
| 2013-09-30 | $428 |
| 2013-06-30 | $397 |
| 2013-03-31 | $388 |
| 2012-12-31 | $375 |
| 2012-09-30 | $410 |
| 2012-06-30 | $381 |
| 2012-03-31 | $380 |
| 2011-12-31 | $366 |
| 2011-09-30 | $374 |
| 2011-06-30 | $352 |
| 2011-03-31 | $328 |
| 2010-12-31 | $310 |
| 2010-09-30 | $327 |
| 2010-06-30 | $301 |
| 2010-03-31 | $291 |
| 2009-12-31 | $356 |
| 2009-09-30 | $336 |
| 2009-06-30 | $316 |
| 2009-03-31 | $305 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.140B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $210.506B | 96.57 |
| Thermo Fisher Scientific (TMO) | United States | $202.042B | 24.50 |
| Alcon (ALC) | Switzerland | $44.047B | 29.47 |
| Edwards Lifesciences (EW) | United States | $42.914B | 27.77 |
| IDEXX Laboratories (IDXX) | United States | $37.709B | 43.46 |
| DexCom (DXCM) | United States | $35.463B | 55.00 |
| IQVIA Holdings (IQV) | United States | $34.295B | 19.00 |
| Mettler-Toledo (MTD) | United States | $27.400B | 31.83 |
| Waters (WAT) | United States | $22.520B | 31.95 |
| STERIS (STE) | Ireland | $21.977B | 25.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.361B | 0.00 |
| Hologic (HOLX) | United States | $14.588B | 15.74 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.679B | 14.04 |
| Sysmex ADR (SSMXY) | Japan | $11.343B | 35.57 |
| Penumbra (PEN) | United States | $11.081B | 100.24 |
| Globus Medical (GMED) | United States | $10.896B | 25.48 |
| Teleflex (TFX) | United States | $8.250B | 13.16 |
| Glaukos (GKOS) | United States | $6.850B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.269B | 23.96 |
| PROCEPT BioRobotics (PRCT) | United States | $3.400B | 0.00 |
| Veracyte (VCYT) | United States | $3.050B | 55.44 |
| LivaNova (LIVN) | United Kingdom | $2.688B | 15.52 |
| Nihon Kohden (NHNKY) | Japan | $2.652B | 14.49 |
| TransMedics (TMDX) | United States | $2.588B | 82.04 |
| Elekta AB (EKTAY) | Sweden | $2.198B | 19.76 |
| Tandem Diabetes Care (TNDM) | United States | $2.145B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.701B | 8.89 |
| Alphatec Holdings (ATEC) | United States | $1.526B | 0.00 |
| RxSight (RXST) | United States | $1.181B | 0.00 |
| OPKO Health (OPK) | United States | $1.174B | 0.00 |
| Artivion (AORT) | United States | $1.167B | 111.40 |
| Pulse Biosciences (PLSE) | United States | $1.154B | 0.00 |
| Paragon 28 (FNA) | United States | $1.092B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.883B | 0.00 |
| AxoGen (AXGN) | United States | $0.793B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.791B | 17.30 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.718B | 12.21 |
| IRadimed (IRMD) | United States | $0.699B | 36.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.694B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.597B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.452B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.449B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.446B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.411B | 9.04 |
| AngioDynamics (ANGO) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.404B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.86 |
| CVRx (CVRX) | United States | $0.343B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.261B | 0.00 |
| Inogen (INGN) | United States | $0.234B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| Accuray (ARAY) | United States | $0.212B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.135B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.121B | 0.00 |
| LENSAR (LNSR) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| InspireMD (NSPR) | Israel | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.093B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.085B | 12.98 |
| Lucid Diagnostics (LUCD) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.58 |
| Microbot Medical (MBOT) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |